Smith Stan 4
4 · MAIA Biotechnology, Inc. · Filed Jan 12, 2026
Insider Transaction Report
Form 4
Smith Stan
Director
Transactions
- Purchase
Common Stock
[F1]2022-09-19$3.69/sh+2,700$9,959→ 1,424,178 total(indirect: See Footnote) - Gift
Common Stock
[F2][F1]2024-05-01+20,000→ 1,444,178 total(indirect: See Footnote)
Holdings
- 4,580(indirect: See footnote)
Common Stock
[F3] - 4,580(indirect: See footnote)
Common Stock
[F4] - 4,580(indirect: See footnote)
Common Stock
[F5]
Footnotes (5)
- [F1]These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
- [F2]These securities were beneficially owned by Mr. Smith through the Stan V Smith CUST Gage Quentin Smith IL UNIF TRNS MIN Act account. On May 1, 2024, the shares were transferred to The Stan V. Smith Trust Dated 1993.
- [F3]These securities are beneficially owned by Mr. Smith through the Blake Sarai Teitei Smith IL Unif Trns Min Act. They are beneficially owned by Mr. Smith's family member. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F4]These securities are beneficially owned by Mr. Smith through the Gage Quentin Smith IL Unif Trns Min Act. They are beneficially owned by Mr. Smith's family member. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F5]These securities are beneficially owned by Mr. Smith through the Travis Deo Zai Zai Smith IL Unif Trns Min Act. They are beneficially owned by Mr. Smith's family member. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Signature
/s/ Stan V. Smith|2026-01-12